Legal protection of the rights of clinical trial subjects in China

Yuanpeng Ren, Xinrui Jin, Shan Jiang, Baisheng Jiang

Journal of Biomedical Research ›› 2018, Vol. 32 ›› Issue (2) : 77-80.

PDF(89 KB)
PDF(89 KB)
Journal of Biomedical Research ›› 2018, Vol. 32 ›› Issue (2) : 77-80. DOI: 10.7555/JBR.32.20170073
Perspective
Perspective

Legal protection of the rights of clinical trial subjects in China

Author information +
History +

Cite this article

Download citation ▾
Yuanpeng Ren, Xinrui Jin, Shan Jiang, Baisheng Jiang. Legal protection of the rights of clinical trial subjects in China. Journal of Biomedical Research, 2018, 32(2): 77‒80 https://doi.org/10.7555/JBR.32.20170073

References

[1]
World Medical Association. WMA declaration of Helsinki – ethical principles for medical research involving human subjects[C/OL]. The 18th WMA General Assembly, Helsinki, Finland, June 1964[2017-03-29]. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.
[2]
Man HJ. Law study on human trials[D]. Shanghai: Fudan University, 2009.
[3]
Wei S, Cong HQ. Protection of human rights in clinical trials[J]. Med and Philos, 2011, 01: 17–19.
[4]
Shao R, Zhang Y, Wang ZM, Comparison on clinical drug research subjects between China and England from the perspective of ethics committee[J]. Chinese Pharmaceut Affairs, 2012, 09: 931–935.
[5]
Li JM. Discussion on standard management in institutional review board for clinical trials in China[J]. Zhongguo Lin Chuang Yao Li Xue Za Zhi, 2009, 25(2): 169–171.
[6]
Qiu R, Zhai XM. The construction of ethics review capacity in China under the current international conditions: Conception and Practice, Chinese[J]. Med Ethics (Burlingt, Mass), 2008, 21(2): 3–5.
[7]
Du WL. Wu D. Current situation and suggestion on drug clinical trials examined by ethics committee[J]. Chinese J Clin Ration Drug Use, 2014, 02: 159–160.
[8]
Zhang W. System establishment of subjects’ rights and interest protection in human trials[J]. Econom Res Guide, 2015, (3): 324–326.
[9]
Wu J, Tang Q. Legal issues on civil damage compensation lawsuit in new drug human trials[J]. The People’s Judicature (in Chinese), 2010, 07: 96–99.
[10]
Zheng S. Human trials under the perspective of civil litigation—in the perspective of subjects’ right to be informed[J]. Law Sci Magazine, 2012, 33(4): 180–185.
[11]
Xin L. A study of the legal issue about the drug clinical trial involved minor subjects[J]. Med and Philos, 2009, 02: 48–50.

Acknowledgments

This article was funded by the National Social Science Foundation of China (Grant No.14BFX161).

RIGHTS & PERMISSIONS

2018 2018 by the Journal of Biomedical Research.
PDF(89 KB)

Accesses

Citations

Detail

Sections
Recommended

/